Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lupeol in Mild to Moderate Acne
NCT02205892Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2014
- Primary completion
- Sep 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in acne vulgaris comparing Lupeol Side with Vehicle Side (2 arms). Primary endpoint: Percent change of inflammatory acne lesion counts at 4 weeks. Started Aug 2014; status: completed.
02
Drugs
Lupeol
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02205892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205892.